This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 1106724
Submitted by lobbyist on: February 4, 2020 08:13:11 AM
Accepted by Registrar on: February 4, 2020 04:00:30 PM
Designated Filer Information
Robidoux, Michel |
110 rue de Lauzon | |
Boucherville, QC, J4B 1E6
|
450-641-4903 |
Canada |
Organization Information
Sandoz Canada Inc. |
Sandoz is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to discover new ways to improve and extend people's lives. For further information please visit www.sandoz.ca |
110 rue de Lauzon | |
Boucherville, QC, J4B 1E6
|
450-641-4903 |
Canada |
Relevant Affiliates
Type:
Business Name | Mailing Address | Contact Information |
---|---|---|
Novartis Pharmaceuticals Inc. |
385 Boul Bouchard
Dorval, QC H9S 1A9 Canada |
Phone: 514-631-6775 |
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
February 4, 2020 | |
August 4, 2020 |
Organization's In-House Lobbyists
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raising awareness to government officials of generics and Biosimilars products development by Sandoz Canada and the potential savings realized by healthcare system. Improve regulatory environment and utilization rates for generics and Biosimilars. Improve regulatory environment to allow pharmacies in British Columbia to sell and distribute medical cannabis to patients.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Minister | Darcy, Judy | Minister of Mental Health and Addictions | February 4, 2020 |
Minister | Dix, Adrian | Minister of Health | February 4, 2020 |
Minister | Eby, David | Minister of Attorney General | February 4, 2020 |
Public Agency | Health | February 4, 2020 | |
Public Agency | Mental Health and Addictions | February 4, 2020 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raising awareness to government officials of generics and Biosimilars products development by Sandoz Canada and the potential savings realized by healthcare system. Improve regulatory environment and utilization rates for generics and Biosimilars.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Public Agency | Health | February 4, 2020 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raising awareness to government officials of generics and Biosimilars products development by Sandoz Canada and the potential savings realized by healthcare system. Improve regulatory environment and utilization rates for generics and Biosimilars.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Minister | Dix, Adrian | Minister of Health | February 4, 2020 |
Staff of Minister | Singh, Jasmyn | Minister of Health | February 4, 2020 |
Public Agency | Health | February 4, 2020 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raising awareness to government officials of generics and Biosimilars products development by Sandoz Canada and the potential savings realized by healthcare system. Improve regulatory environment and utilization rates for generics and Biosimilars. Improve regulatory environment to allow pharmacies in British Columbia to sell and distribute medical cannabis to patients.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Minister | Darcy, Judy | Minister of Mental Health and Addictions | February 4, 2020 |
Minister | Dix, Adrian | Minister of Health | February 4, 2020 |
Minister | Eby, David | Minister of Attorney General | February 4, 2020 |
Minister | Horgan, John | Premier | February 4, 2020 |
Minister | James, Carole | Minister of Finance | February 4, 2020 |
Staff of Minister | Singh, Jasmyn | Minister of Health | February 4, 2020 |
MLA | Cadieux, Stephanie | Surrey South | February 4, 2020 |
MLA | Isaacs, Joan | Coquitlam-Burke Mountain | February 4, 2020 |
MLA | Yap, John | Richmond-Steveston | February 4, 2020 |
Public Agency | Health | February 4, 2020 | |
Public Agency | Mental Health and Addictions | February 4, 2020 | |
Public Agency | University of British Columbia | February 4, 2020 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raising awareness to government officials of generics and Biosimilars products development by Sandoz Canada and the potential savings realized by healthcare system. Improve regulatory environment and utilization rates for generics and Biosimilars.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Public Agency | Health | February 4, 2020 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raising awareness to government officials of generics and Biosimilars products development by Sandoz Canada and the potential savings realized by healthcare system. Improve regulatory environment and utilization rates for generics and Biosimilars. Improve regulatory environment to allow pharmacies in British Columbia to sell and distribute medical cannabis to patients.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Minister | Darcy, Judy | Minister of Mental Health and Addictions | February 4, 2020 |
Minister | Dix, Adrian | Minister of Health | February 4, 2020 |
Minister | Eby, David | Minister of Attorney General | February 4, 2020 |
Public Agency | Health | February 4, 2020 | |
Public Agency | Mental Health and Addictions | February 4, 2020 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raising awareness to government officials of biosimilars products development by Sandoz Canada and the potential savings realized by healthcare system. Improve regulatory environment and utilization rates for biosimilars.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Public Agency | Health | February 4, 2020 | |
Public Agency | Provincial Health Services Authority | February 4, 2020 | |
Public Agency | University of British Columbia | February 4, 2020 |